Literature DB >> 361306

Duodenitis.

S N Joffe, F D Lee, L H Blumgart.   

Abstract

Many questions regarding duodenitis remain unanswered. However, the evidence suggests that duodenitis is a clinical entity which can give rise to dyspepsia and, on rare occasions, gastrointestinal haemorrhage. Conventional and double contrast radiology has only a small part to play in the diagnosis of duodenitis but is important in helping to exclude other lesions such as duodenal ulcer. Provided care is taken during the fibre-optic visualization of the duodenal bulb, the endoscopic appearances of moderately severe duodenitis correlate well with the histological changes seen. A diagnosis of apparent duodenitis should be confirmed by the histological criteria described. Treatment at present is similar to that of peptic ulcer, with the withdrawal of any predisposing and precipitating factors such as aspirin, alcohol and smoking. Antacids may relieve the symptoms. It is not yet known what effect these measures may have on the duodenitis as opposed to the symptoms of dyspepsia. The H2-receptor antagonist, cimetidine, should be effective in treating duodenitis but double blind clinical and endoscopic studies are required to confirm this. The place of surgery is as yet undefined. With the data at present available, it appears that duodenitis is part of the pathophysiological spectrum of the duodenal ulcer diathesis rather than a separate disease. It may represent both the production and healing phases of duodenal ulceration. In some patients the duodenal mucosa may proceed from normal to duodenitis and then to normal again without the development of frank duodenal ulceration (Figure 4). Prospective studies are required which should include a long-term clinical follow-up of a large number of patients with duodenitis accurately and specifically diagnosed by endoscopy and histopathology.

Entities:  

Mesh:

Year:  1978        PMID: 361306

Source DB:  PubMed          Journal:  Clin Gastroenterol        ISSN: 0300-5089


  15 in total

1.  Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation.

Authors:  J I Wyatt; B J Rathbone; G M Sobala; T Shallcross; R V Heatley; A T Axon; M F Dixon
Journal:  J Clin Pathol       Date:  1990-12       Impact factor: 3.411

2.  Duodenal ulcer: the villain unmasked?

Authors:  A R Axon
Journal:  BMJ       Date:  1991-04-20

3.  Nature of the inflammatory cell infiltrate in duodenitis.

Authors:  M Hasan; F Hay; W Sircus; A Ferguson
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

4.  Duodenal mucosal architecture in non-specific and ulcer-associated duodenitis.

Authors:  M Hasan; W Sircus; A Ferguson
Journal:  Gut       Date:  1981-08       Impact factor: 23.059

5.  Helicobacter pylori and associated duodenal ulcer.

Authors:  C K Yeung; K H Fu; K Y Yuen; W F Ng; T M Tsang; F J Branicki; H Saing
Journal:  Arch Dis Child       Date:  1990-11       Impact factor: 3.791

6.  Defining duodenitis: quantitative histological study of mucosal responses and their correlations.

Authors:  D Jenkins; A Goodall; F R Gillet; B B Scott
Journal:  J Clin Pathol       Date:  1985-10       Impact factor: 3.411

7.  Gastroduodenal inflammation in patients with non-ulcer dyspepsia. A controlled endoscopic and morphometric study.

Authors:  A U Toukan; M F Kamal; S S Amr; M A Arnaout; A S Abu-Romiyeh
Journal:  Dig Dis Sci       Date:  1985-04       Impact factor: 3.199

8.  Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis.

Authors:  J I Wyatt; B J Rathbone; M F Dixon; R V Heatley
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

9.  Natural history of chronic duodenitis: incidence in Nigerians.

Authors:  E A Ayoola; M A Atoba; E A Lewis
Journal:  J Natl Med Assoc       Date:  1981-08       Impact factor: 1.798

10.  Outcome of ulcer-associated duodenitis after short-term medical treatment.

Authors:  P Paoluzi; F Pallone; E Zaccardelli; F Ripoli; A Marcheggiano; R Carratù
Journal:  Dig Dis Sci       Date:  1985-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.